Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
N-acetylcysteine in Co-occurring Bipolar and Alcohol Use Disorders
NCT07913542Phase 2Not yet recruiting
- Sponsor
- Medical University of South Carolina
- Start
- Jan 2027
- Primary completion
- Aug 2031
- Countries
- 1
01
Overview
A Phase 2 trial of acetylcysteine in bipolar disorder (BD), alcohol use disorder (AUD), sponsored by Medical University of South Carolina. Planned start Jan 2027; status: not yet recruiting.
02
Drugs
acetylcysteine
03
Conditions
bipolar disorder (BD)alcohol use disorder (AUD)
Beyond the preview
Go deeper on NCT07913542.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07913542.